Đang chuẩn bị liên kết để tải về tài liệu:
Biosimilar filgrastim treatment patterns and prevention of febrile neutropenia: A prospective multicentre study in France in patients with solid tumours (the ZOHé study)

Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ

The ZOHé study was a prospective, non-interventional, multicentre study in France to assess the use of biosimilar filgrastim Zarzio® (Sandoz filgrastim) in routine clinical practice in patients at risk of neutropeniainducing chemotherapy (CT). | Biosimilar filgrastim treatment patterns and prevention of febrile neutropenia A prospective multicentre study in France in patients with solid tumours the ZOHé study

TÀI LIỆU LIÊN QUAN

Preclinical and clinical phase I studies of a new recombinant Filgrastim (BK0023) in comparison with Neupogen®

Study design: Two long-term observational studies of the biosimilar filgrastim Nivestim™ (Hospira filgrastim) in the treatment and prevention of chemotherapy-induced neutropenia

Biosimilar filgrastim treatment patterns and prevention of febrile neutropenia: A prospective multicentre study in France in patients with solid tumours (the ZOHé study)